NEWMAN MICHAEL JAMES (Chief Scientific Officer) received a stock award from INDAPTUS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/29/2025ACC: 0001493152-25-029354
DirectorOfficer10% Owner· Chief Scientific Officer
Since Aug 2021
+52.20K
Net shares
Net buyer
$106.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
52.20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+52.20K
Price / share
$2.03
Trade value
$105.97K
% of position
106.8%
12/22/2025
48.87K→101.07K
Total
Net shares
+52.20K
Net value
$105.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/22/2025 | A · Award | +52.20K | $2.03 | $105.97K | 106.8% | 48.87K | 101.07K |
| Total | +52.20K | $105.97K | ||||||
Derivative Transactions0
No derivative transactions reported